AIC
BBC icon

Ameritas Investment Company’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Ameritas Investment Company’s Portfolio BBC Stock Details BBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-200
Closed -$5K – 1040
2018
Q4 		$5K Buy
+200
New +$5.46K ﹤0.01% 1200

Other funds holding BBC

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
AWCI
Alpine Woods Capital Investors Purchase, New York $417M AUM 26.83% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ameritas Investment Company's BBC Position: Q1 2019 in Review

Ameritas Investment Company sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q1 2019, closing a stake of 200 shares — an estimated $5K sold.

Ameritas Investment Company first reported a position in BBC in Q4 2018 and held it in 1 quarter. The position peaked at $5K in Q4 2018. 15 funds tracked by Wall St. Rank hold BBC as of Q1 2019.

  • Ameritas Investment Company reported no remaining Virtus Biotech Clinical Trials ETF position as of Q1 2019 after selling out during the quarter.
  • Ameritas Investment Company sold 200 Virtus Biotech Clinical Trials ETF shares in Q1 2019, an estimated $5K.
  • Ameritas Investment Company first reported a position in Virtus Biotech Clinical Trials ETF in Q4 2018 and held it in 1 quarter.
  • Ameritas Investment Company's Virtus Biotech Clinical Trials ETF position peaked at $5K in Q4 2018.
  • 15 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q1 2019.

Based on Ameritas Investment Company's 13F filing for Q1 2019, filed 16 May 2019.